Copyright Reports & Markets. All rights reserved.

Global Engineered T Cells Market Research Report 2012-2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Tumor Infiltrating Lymphocytes
        • 1.2.1.2 T Cell Receptor {TCR}
        • 1.2.1.3 Chimeric Antigen Receptor (CAR)
      • 1.2.2 by Application
        • 1.2.2.1 Hospitals
        • 1.2.2.2 Cancer Research Centers
        • 1.2.2.3 Clinics
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Tumor Infiltrating Lymphocytes Market, 2013-2018
      • 4.1.2 T Cell Receptor {TCR} Market, 2013-2018
      • 4.1.3 Chimeric Antigen Receptor (CAR) Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Tumor Infiltrating Lymphocytes Market Forecast, 2019-2024
      • 4.2.2 T Cell Receptor {TCR} Market Forecast, 2019-2024
      • 4.2.3 Chimeric Antigen Receptor (CAR) Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Hospitals Market, 2013-2018
      • 5.1.2 Cancer Research Centers Market, 2013-2018
      • 5.1.3 Clinics Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Hospitals Market Forecast, 2019-2024
      • 5.2.2 Cancer Research Centers Market Forecast, 2019-2024
      • 5.2.3 Clinics Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Autolus Limited
    • 8.2 Bellicum Pharmaceuticals
    • 8.3 Cells Medica
    • 8.4 Elli Lilly and Company
    • 8.5 Gilead Sciences
    • 8.6 Juno Therapeutics
    • 8.7 Novartis
    • 8.8 Oxford Biomedica
    • 8.9 Pfizer
    • 8.10 Precision Bioscience
    • 8.11 Redmile Group
    • 8.12 Seeking Alpha
    • 8.13 Unum Therapeutics

    9 Conclusion

    Summary
    The global Engineered T Cells market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Tumor Infiltrating Lymphocytes
    T Cell Receptor {TCR}
    Chimeric Antigen Receptor (CAR)
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Autolus Limited
    Bellicum Pharmaceuticals
    Cells Medica
    Elli Lilly and Company
    Gilead Sciences
    Juno Therapeutics
    Novartis
    Oxford Biomedica
    Pfizer
    Precision Bioscience
    Redmile Group
    Seeking Alpha
    Unum Therapeutics
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Hospitals
    Cancer Research Centers
    Clinics
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now